ClinicalTrials.govpublic full text
Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma
kidney, cancer, combination therapy, 5-fluorouracil, interferon-a interleukin-2, thalidomide, renal cell carcinoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 904139
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.